Gilead markets Sovaldi and Harvoni, while AbbVie sells Viekera Pak. (Silverman, 5/12) CQ Healthbeat: VA Seeks More Money For Hepatitis Drugs, New Choice Criteria A top Department of Veterans Affairs official asked senators Tuesday to pass legislation that would allow the agency to shift some funds for private, non-VA care to pay for expensive hepatitis C drugs and further adjust eligibility criteria for a program that Congress created last year known as the Choice program. Deputy Secretary Sloan Gibson presented the requests to the Senate Veterans' Affairs Committee at a hearing Tuesday afternoon. (Adams, 5/12) The Associated Press: Lawmakers To VA: Find Another Way To Pay For Denver Hospital Lawmakers from both parties said Tuesday they will not divert money from a new health care law to pay for a half-finished hospital in Denver that now is expected to cost more than $1.7 billion — nearly triple an estimate the Department of Veterans Affairs gave last year.